0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Economics, Pharma 11/2/11 Economics, Pharma 11/2/11

Lipitor: How Pfizer hopes to slow the decline

Read More
International, Pharma 10/27/11 International, Pharma 10/27/11

Is Southern Europe's debt crisis an omen for US health care?

Read More
Pharma, Policy and politics, Research 10/24/11 Pharma, Policy and politics, Research 10/24/11

Xigris withdrawal highlights conflict of interest problems

Read More
Economics, Pharma, Policy and politics 9/27/11 Economics, Pharma, Policy and politics 9/27/11

Right result, wrong reason: VA boots Avastin for wet AMD

Read More
e-health, Health plans, Pharma, Physicians, Podcast 9/23/11 e-health, Health plans, Pharma, Physicians, Podcast 9/23/11

NaviNet execs discuss Mobile Connect for PBMs (podcast)

Read More
Amusements, Pharma 9/12/11 Amusements, Pharma 9/12/11

Nouveau riche Chinese pharma company must learn to be more discreet

Read More
Culture, Pharma, Physicians 9/7/11 Culture, Pharma, Physicians 9/7/11

What the Talmud teaches about drug company gifts to doctors

Read More
Pharma, Policy and politics 8/30/11 Pharma, Policy and politics 8/30/11

Niche blockbusters: the next drug cost crisis?

Read More
Pharma 8/17/11 Pharma 8/17/11

Smart money on Pfizer?

Read More
Health plans, Pharma, Policy and politics 8/2/11 Health plans, Pharma, Policy and politics 8/2/11

Drug co-pay cards: Can we all just get along?

Read More
Pharma, Technology 5/20/11 Pharma, Technology 5/20/11

Being a pharma rep isn't as much fun as it was. And you can't really blame the iPad

Read More
e-health, Pharma 5/13/11 e-health, Pharma 5/13/11

I'm giving Google the benefit of the doubt on settlement of 'rogue pharmacy' ads complaint

Read More
Pharma, Policy and politics 4/27/11 Pharma, Policy and politics 4/27/11

A terribly bad idea: US vs. Forest Labs

Read More
Patients, Pharma, Research 4/26/11 Patients, Pharma, Research 4/26/11

Let's give patients a little more credit for their role in clinical research

Read More
Blogs, Pharma, Podcast 4/7/11 Blogs, Pharma, Podcast 4/7/11

Yours truly on Pixels & Pills

Read More
Entrepreneurs, Patients, Pharma 4/7/11 Entrepreneurs, Patients, Pharma 4/7/11

Ex-AOL TimeWarner CEO Levin on DTC in health care

Read More
Pharma, Policy and politics 3/29/11 Pharma, Policy and politics 3/29/11

Conflicts of interest in guideline development: a dirty little secret gets aired again

Read More
Pharma, Policy and politics 3/4/11 Pharma, Policy and politics 3/4/11

Why you shouldn't feel good about paying a low price for wet AMD treatment

Read More
Pharma, Policy and politics, Research 3/3/11 Pharma, Policy and politics, Research 3/3/11

Quality of life adjustments don't matter much for cancer treatment cost effectiveness

Read More
Pharma, Policy and politics 2/15/11 Pharma, Policy and politics 2/15/11

Patent settlements: Ban or maybe tax instead?

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.